Anavex Life Sciences Corp.

AVXL

As of the close on Sep 25, 2026

Price

$2.38

Market cap

—

The latest share count on file is too old

P/E (diluted TTM)

—

The latest quarterly report is not on file yet

EPS (TTM)

—

The latest quarterly report is not on file yet

Dividend yield

—

Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Anavex Life Sciences Corp. Makes Money

No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 16 annual periods. The latest annual period ends Sep 30, 2025. The latest insider filing shown is dated Jan 9, 2026. The latest institutional report shown is dated Sep 30, 2025; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer	Report date	Shares	Value	Filing
Byrne Asset Management LLC	2025-09-30	6,400	Not shown	SEC filing
Byrne Asset Management LLC	2025-03-31	4,642	Not shown	SEC filing
Byrne Asset Management LLC	2024-12-31	1,620	Not shown	SEC filing
Byrne Asset Management LLC	2024-09-30	2,500	Not shown	SEC filing

Each value is checked against Anavex Life Sciences Corp.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
Value not shown for 4 rows: no share price from within three months of their report dates is on file, so they could not be checked.

Filer report history

Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.

Byrne Asset Management LLC: 4,642 shares reported 2025-03-31; 6,400 shares reported 2025-09-30.
Byrne Asset Management LLC: 1,620 shares reported 2024-12-31; 4,642 shares reported 2025-03-31.
Byrne Asset Management LLC: 2,500 shares reported 2024-09-30; 1,620 shares reported 2024-12-31.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Anavex Life Sciences Corp.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

2024-06-14 · Donhauser Peter D.O.: Larger than 29 of the 30 other insider purchases of Common Stock on file. SEC filing
2024-05-15 · Thomas Steffen: Larger than all 30 other insider purchases of Common Stock on file. SEC filing
2018-03-05 · MISSLING CHRISTOPHER U: Larger than 27 of the 30 other insider purchases of Common Stock on file. SEC filing
2018-03-02 · MISSLING CHRISTOPHER U: Larger than 28 of the 30 other insider purchases of Common Stock on file. SEC filing
2009-06-29 · Skarpelos Athanasios: Larger than all 12 other insider sales of common stock on file. SEC filing

Independent insiders buying near the same time

2007-02-08–2007-02-08: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2024-06-14	Donhauser Peter D.O. · Director	Common Stock	P — Open market or private purchase	+2,835	3.64	SEC filing
2024-05-15	Thomas Steffen · Director	Common Stock	P — Open market or private purchase	+5,000	4.52	SEC filing
2024-03-28	MISSLING CHRISTOPHER U · President and CEO	Common Stock	S — Open market or private sale	−73,380	5.11	SEC filing
2023-06-28	MISSLING CHRISTOPHER U · President and CEO	Common Stock	S — Open market or private sale	−268,000	7.98	SEC filing
2022-05-25	Skarpelos Athanasios · Director	Common Stock	S — Open market or private sale	−50,000	9.06	SEC filing
2021-06-29	Boenisch Sandra · PFO and Treasurer	Common Stock	S — Open market or private sale	−166,696	26.53	SEC filing
2021-06-29	MISSLING CHRISTOPHER U · President and CEO	Common Stock	S — Open market or private sale	−51,620	26.00	SEC filing
2021-05-21	FAVUS ELLIOT · Director	Common Stock	S — Open market or private sale	−145,000	11.70	SEC filing

Showing 8 of 20 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-01-06	MISSLING CHRISTOPHER U · President and CEO	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+125,000	SEC filing
2026-01-06	Boenisch Sandra · PFO & Treasurer	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+12,500	SEC filing
2025-10-02	MISSLING CHRISTOPHER U · President and CEO	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+125,000	SEC filing
2025-10-02	Boenisch Sandra · PFO & Treasurer	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+12,500	SEC filing
2025-09-11	MISSLING CHRISTOPHER U · President and CEO	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−187,500	SEC filing
2025-09-11	MISSLING CHRISTOPHER U · President and CEO	Common Stock	M — Exercise or conversion of derivative security	+187,500	SEC filing
2025-09-11	MISSLING CHRISTOPHER U · President and CEO	Common Stock	F — Payment of exercise price or tax by delivering securities	−145,048	SEC filing
2025-08-20	MISSLING CHRISTOPHER U · President and CEO	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+125,000	SEC filing

Showing 8 of 26 rows

Other activity

		Security	Code		Filing
2012-02-09	TIDMARSH GEORGE F · Executive Director	common stock	J — Other acquisition or disposition	+8,000	SEC filing
2012-02-09	TIDMARSH GEORGE F · Executive Director	warrants	J — Other acquisition or disposition	+4,000	SEC filing
2009-06-18	Durrant Cameron · Director	common stock	J — Other acquisition or disposition	−75,000	SEC filing
2006-06-12	Lalach Harvey · President & CEO	Common	J — Other acquisition or disposition	+500,000	SEC filing
2006-06-12	Skarpelos Athanasios · 10% owner	common	J — Other acquisition or disposition	+7,812,500	SEC filing

Showing 5 of 5 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.